Bibliografía del artículo
1. Raney RB: Soft-tissue sarcoma in childhood and adolescence. Curr Oncol Rep 2002; 4:291-298.2. Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer. Mechanism, reversal using modulators and the role of MDR modulators in influencing the pharmacokinetics of anticancer. Eur J Pharm Sci 2000; 11:265-283.3. Komdeur R, Plaat BE, Van der Graf WT, Hoekstra HJ, Hollema H et al. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade. Eur J Cancer. 2003; 39:909-916.4. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene 2003, 22:7468-7685.5. Breier A, Barancik M, Sulova Z, Uhrik B. P-glycoprotein-implications of metabolism of neoplastic cells and cancer therapy. Curr Cancer Drug Targets 2005; 5:457-468.6. Melguizo C, Prados J, Marchal JA, Vélez C, Carrilo E et al. Expression of HLA Class I but not HLA Class II antigens is modulated by P-glycoprotein in resistant human rhabdomyosarcoma cells. Neoplasma 2003; 50:91-96.7. García Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 2003; 195:346-355.8. Ramnath N, Tan D, Li Q, Hylander BL, Bogner P et al. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival Cancer Immunol Immunother 2005; 27:1-9.9. Melguizo C, Prados J, Aneiros J, Fernández JE, Vélez C et al. Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment. J Pathol 1995; 175:23-39.10. Leuschner I, Heuer T, Harms D. Induction of drug resistance in human rhabdomyosarcoma cell lines is associated with increased maturation: possible explanation for differentiation in recurrences. Pediatr Devel Pathol 2002; 5:276-282.11. Staibano S, Franco R, Mezza E, Lo Muzio L, Strianese D et al. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior. Anticancer Res 2004, 24:249-257.12. Leuschner I, Harms D, Mattke A, Koscielniak E, Treuner J. Rhabdomyosarcoma of the urinary bladder and vagina: a clinicophatologic study with emphasis of recurrent disease: a report of the Kiel Pediatric Tumo.13. García Lora A,. Algarra I, Collado A, Garrido F. Tumour immunology, vaccination and escape strategies. Eur J Immunogenet 2003; 30:177-183.14. Gallego S, Llort A, Parareda A, Sánchez de Toledo J. Expression of multidrug resistance-1 and multidrug resistance-associated protein genes in pediatric rhabdomyosarcoma. Oncol Rep 2004; 11:179-183.15. Ramnath N, Tan D, Li Q, Hylander BL, Bogner P et al. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival Cancer Immunol Immunother 2005; 27:1-9.